Xiaojun Liu Selected Research

Xiaojun Liu Research Topics

Disease

79	Neoplasms (Cancer) 10/2022 - 09/2007
11	Neoplasm Metastasis (Metastasis) 05/2021 - 09/2010
10	Body Weight (Weight, Body) 01/2020 - 11/2013
10	Hematologic Neoplasms (Hematological Malignancy) 01/2018 - 08/2005
8	Carcinogenesis 01/2021 - 12/2013
8	Stomach Neoplasms (Stomach Cancer) 12/2017 - 03/2013
7	Inflammation (Inflammations) 02/2022 - 09/2012
7	Myocardial Infarction 02/2022 - 10/2009
6	Cardiovascular Diseases (Cardiovascular Disease) 03/2021 - 06/2007
6	Vascular Diseases (Vascular Disease) 01/2020 - 06/2007
5	Heart Failure 01/2022 - 01/2018
5	Atherosclerosis 01/2022 - 06/2007
5	Ovarian Neoplasms (Ovarian Cancer) 03/2021 - 01/2018
5	Insulin Resistance 01/2019 - 09/2015
4	Hypoxia (Hypoxemia) 02/2022 - 05/2016
4	Thrombosis (Thrombus) 02/2021 - 11/2011
4	Chromosome Aberrations (Chromosome Abnormalities) 12/2019 - 08/2005
4	Lung Neoplasms (Lung Cancer) 07/2019 - 11/2014
4	Pathologic Processes 03/2017 - 09/2012
4	Lymphatic Metastasis 12/2016 - 09/2010
4	Ischemia 06/2014 - 10/2009
4	Leukemia 05/2014 - 10/2006
3	Wounds and Injuries (Trauma) 06/2022 - 05/2012
3	Hemorrhage 06/2022 - 11/2016
3	Necrosis 02/2022 - 04/2010
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 09/2015
3	Esophageal Neoplasms (Esophageal Cancer) 01/2021 - 01/2019
3	Hepatocellular Carcinoma (Hepatoma) 04/2020 - 01/2016
3	Breast Neoplasms (Breast Cancer) 01/2020 - 01/2011
3	Obesity 10/2018 - 09/2015
3	Hypertension (High Blood Pressure) 01/2018 - 06/2007
3	Mouth Neoplasms (Oral Cancer) 03/2014 - 09/2010
3	Heart Diseases (Heart Disease) 08/2010 - 06/2007
2	Coronary Artery Disease (Coronary Atherosclerosis) 10/2022 - 02/2017
2	Renal Cell Carcinoma (Grawitz Tumor) 05/2022 - 01/2017
2	Pain (Aches) 04/2022 - 02/2014
2	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 02/2010
2	Carcinoma (Carcinomatosis) 01/2022 - 10/2017
2	COVID-19 01/2022 - 01/2021
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2021 - 01/2021
2	Atrial Fibrillation 12/2020 - 12/2018
2	Neuroblastoma 01/2020 - 11/2014
2	Fibrosis (Cirrhosis) 10/2019 - 01/2015

Drug/Important Bio-Agent (IBA)

20	MicroRNAs (MicroRNA)IBA 01/2021 - 06/2007
13	Proteins (Proteins, Gene)FDA Link 02/2022 - 07/2007
12	Pharmaceutical PreparationsIBA 01/2021 - 01/2009
12	Chimeric Antigen ReceptorsIBA 12/2017 - 11/2010
9	Glucose (Dextrose)FDA LinkGeneric 02/2022 - 08/2011
9	RNA (Ribonucleic Acid)IBA 01/2022 - 11/2010
9	Messenger RNA (mRNA)IBA 01/2021 - 11/2010
9	Biomarkers (Surrogate Marker)IBA 07/2020 - 09/2010
8	2'- cyano- 2'- deoxyarabinofuranosylcytosineIBA 12/2019 - 08/2005
6	Long Noncoding RNAIBA 01/2022 - 08/2018
6	Biological ProductsIBA 01/2021 - 06/2009
6	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 07/2007
6	EnzymesIBA 07/2019 - 09/2007
5	Triglycerides (Triacylglycerol)IBA 10/2018 - 08/2011
5	NucleosidesIBA 01/2018 - 01/2008
4	AntigensIBA 01/2021 - 11/2010
4	Therapeutic UsesIBA 04/2020 - 11/2011
4	AntioxidantsIBA 01/2020 - 09/2012
4	pevonedistatIBA 07/2019 - 01/2017
4	AntibodiesIBA 05/2019 - 07/2013
4	sapacitabineIBA 01/2018 - 04/2012
4	ProdrugsIBA 01/2018 - 04/2012
3	Circular RNAIBA 10/2022 - 01/2019
3	Anti-Bacterial Agents (Antibiotics)IBA 04/2022 - 10/2021
3	Small Interfering RNA (siRNA)IBA 03/2021 - 03/2014
3	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2021 - 09/2012
3	Ligases (Synthetase)IBA 01/2020 - 03/2019
3	Interleukin-6 (Interleukin 6)IBA 01/2020 - 12/2013
3	Oxygen (Dioxygen)IBA 01/2018 - 11/2007
3	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2014 - 07/2009
3	shexiang baoxinIBA 03/2014 - 09/2012
2	oxidized low density lipoproteinIBA 10/2022 - 01/2017
2	Hemostatics (Antihemorrhagics)IBA 06/2022 - 11/2016
2	Interleukin-10 (Interleukin 10)IBA 04/2022 - 10/2021
2	HMGB1 Protein (HMG1)IBA 02/2022 - 05/2012
2	InflammasomesIBA 02/2022 - 01/2019
2	Complement System Proteins (Complement)IBA 01/2022 - 11/2010
2	CytokinesIBA 10/2021 - 01/2020
2	Polysaccharides (Glycans)IBA 10/2021 - 01/2021
2	Glutamic Acid (Glutamate)FDA Link 10/2021 - 05/2012
2	PolymersIBA 02/2021 - 07/2020
2	Hormones (Hormone)IBA 01/2021 - 02/2010
2	Silicon Dioxide (Silica)FDA LinkGeneric 01/2021 - 05/2018
2	MicellesIBA 11/2020 - 07/2020
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 01/2020
2	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 06/2015
2	C-Reactive ProteinIBA 01/2020 - 06/2012
2	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2020 - 01/2017
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2020 - 12/2018
2	Fluorescent Dyes (Fluorescent Probes)IBA 11/2019 - 11/2011
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 10/2019 - 11/2017

Therapy/Procedure

17	Therapeutics 05/2022 - 08/2005
7	Drug Therapy (Chemotherapy) 04/2020 - 08/2013
5	Immunotherapy 01/2021 - 11/2014
3	Electrodes (Electrode) 01/2021 - 01/2018
3	Aftercare (After-Treatment) 01/2019 - 10/2009
2	Precision Medicine 01/2021 - 01/2016